APA (7th ed.) Citation

C, S., J, L., B, T., R, N., SP, S., J, H., . . . A, B. (2024). CSF complement proteins are elevated in prodromal to moderate Alzheimer's disease patients and are not altered by the anti-tau antibody semorinemab. Alzheimer's & dementia : the journal of the Alzheimer's Association, 20(11), 7940. https://doi.org/10.1002/alz.14271

Chicago Style (17th ed.) Citation

C, Sandoval, et al. "CSF Complement Proteins Are Elevated in Prodromal to Moderate Alzheimer's Disease Patients and Are Not Altered by the Anti-tau Antibody Semorinemab." Alzheimer's & Dementia : The Journal of the Alzheimer's Association 20, no. 11 (2024): 7940. https://doi.org/10.1002/alz.14271.

MLA (9th ed.) Citation

C, Sandoval, et al. "CSF Complement Proteins Are Elevated in Prodromal to Moderate Alzheimer's Disease Patients and Are Not Altered by the Anti-tau Antibody Semorinemab." Alzheimer's & Dementia : The Journal of the Alzheimer's Association, vol. 20, no. 11, 2024, p. 7940, https://doi.org/10.1002/alz.14271.